Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05043454 · ClinicalTrials.gov registry record · NA

Improving Age-Related Cognitive Decline With Exercise in Hypertensive Older Adults

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT05043454: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT05043454 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05043454, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

The investigator aims to assess the extent to which a brief exercise intervention improves systemic growth factor concentrations, reverses loss of systemic vascular networks and hypertension, and by extension, improves neurocognition. To test the investigator's hypothesis that increased cardiovascular fitness will correlate with improved vascular density, the investigator proposes the innovative use of retinal density scans.

Primary Outcome

This test will measure participants' maximal oxygen utilization and will be done once before and once after exercise intervention. The investigator will use a graded exercise test on a stationary cycle. The test will continue to maximum, and expired gases will be collected (via a spirometer) throughout the test to monitor oxygen consumption and carbon dioxide expiration. The investigator defines maximum or test termination as either voluntary exhaustion by the participant, or by two of three phy

Interventions

  • OTHER High Intensity Interval Training (HIIT) Exercise

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2021-10-01
Est. Completion 2025-07-09
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT05043454 record still lists

NCT05043454 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which High Intensity Interval Training (HIIT) Exercise is the first listed.

NCT05043454 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05043454 about?

NCT05043454 is a clinical study titled "Improving Age-Related Cognitive Decline With Exercise in Hypertensive Older Adults". The investigator aims to assess the extent to which a brief exercise intervention improves systemic growth factor concentrations, reverses loss of systemic vascular networks and hypertension, and by extension, improves neurocognition. To test the investigator's hypothesis that increased cardiovascul...

What is the current status of trial NCT05043454?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-10-01. Estimated completion is 2025-07-09.

What interventions are being tested in trial NCT05043454?

The interventions under investigation include: High Intensity Interval Training (HIIT) Exercise (OTHER).

Who is sponsoring clinical trial NCT05043454?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05043454's enrollment target sits among peer trials

11 1927th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05043454, the US trial registry maintained by the National Library of Medicine. NCT05043454 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.